Sky High Herbals Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
- Paid Up Capital ₹ 0.70 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth -43.47%
- Profit Growth -110.85%
- Ebitda -4.09%
- Net Worth -0.32%
- Total Assets -18.34%
About Sky High Herbals
Sky High Herbals Private Limited (SHHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 2010 and has a history of 14 years and three months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹4.00 M.
Ezhilarasan and Sumathir serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U01135TN2010PTC077753
-
Company No.
077753
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Oct 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sky High Herbals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ezhilarasan
|
Managing Director | 20-Oct-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sumathir
|
Director Appointed In Casual Vacancy | 10-Oct-2017 | Current |
Financial Performance of Sky High Herbals.
Sky High Herbals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 43.47% decrease. The company also saw a substantial fall in profitability, with a 110.85% decrease in profit. The company's net worth dipped by a decrease of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sky High Herbals?
In 2019, Sky High Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2011 | Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Sky High Herbals?
Unlock and access historical data on people associated with Sky High Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sky High Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky High Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
